Dongchun Liu

机构：Shenyang Pharmaceutical University · ORCID：0000-0003-0732-7623

发表论文 41 篇 · 总被引 678 次 · h-index 15

代表论文

• Biopharmaceutical characters and bioavailability improving strategies of ginsenosides (2018 · Fitoterapia · 被引 76)
• Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis (2023 · Nano Letters · 被引 60)
• Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency (2020 · Acta Pharmaceutica Sinica B · 被引 45)
• Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load (2021 · Hepatology International · 被引 40)
• Hydroxycamptothecin (HCPT)-loaded PEGlated lipid–polymer hybrid nanoparticles for effective delivery of HCPT: QbD-based development and evaluation (2021 · Drug Delivery and Translational Research · 被引 33)
• Cancer Cell Membrane-Coated Homodimer Prodrug Nanoassemblies to Simultaneously Deliver Prodrugs and Immune Adjuvants for Combined Chemo-Immunotherapy (2025 · ACS Nano · 被引 29)